Fiducial markers for prostate radiotherapy

Summary

The tender concerns fiducial markers for prostate radiotherapy. The procurement is divided into two lots, and a bidder may submit a tender for one or both lots. The contract period is 2 years, after which it may remain in force until further notice. The estimated start is in the latter part of 2026. The estimated annual volume is about EUR 150,000 excluding VAT, but the contracting entity does not commit to ordering that amount or those quantities.